Latest News in the pharma Industry

Policy & Regulation

FDA Approves New Antiplatelet Drug Used During Heart Procedure?

FDA Approves New Antiplatelet Drug Used During Heart Procedure?

23 Jun 2015

Read more 
NIH Provides Interim Corrective Action Plan for Clinical Center Pharmaceutical Development Section

NIH Provides Interim Corrective Action Plan for Clinical Center Pharmaceutical Development Section

22 Jun 2015

Read more 
Mylan Expands its Voluntary Nationwide Recall of Select Lots of Injectable Products Due to the Presence of Particulate Matter

Mylan Expands its Voluntary Nationwide Recall of Select Lots of Injectable Products Due to the Presence of Particulate Matter

12 Jun 2015

Read more 
FDA Awards Isarna Orphan Drug Designation  for ISTH0036 to Improve Glaucoma Treatment Outcome

FDA Awards Isarna Orphan Drug Designation for ISTH0036 to Improve Glaucoma Treatment Outcome

10 Jun 2015

Read more 
Drug Abuse Triggers Regulations to Push the Development of Tamper-Resistant Opioid Formulations for Pain Management

Drug Abuse Triggers Regulations to Push the Development of Tamper-Resistant Opioid Formulations for Pain Management

8 Jun 2015

Read more 
Shire Receives European Approval to Use Resolor (Prucalopride) in Men for the Symptomatic Treatment of Chronic Constipation

Shire Receives European Approval to Use Resolor (Prucalopride) in Men for the Symptomatic Treatment of Chronic Constipation

4 Jun 2015

Read more 
EMA Validates Gilead’s Marketing Application for Fixed-Dose Combination of Emtricitabine and Tenofovir Alafenamide for HIV Treatment

EMA Validates Gilead’s Marketing Application for Fixed-Dose Combination of Emtricitabine and Tenofovir Alafenamide for HIV Treatment

29 May 2015

Read more 
Merck Submits US NDA for Grazoprevir Elbasvir for Treatment of Chronic Hepatitis C Genotypes 1, 4, and 6 Infection

Merck Submits US NDA for Grazoprevir Elbasvir for Treatment of Chronic Hepatitis C Genotypes 1, 4, and 6 Infection

29 May 2015

Read more 
Antibiotic Approved for Treating Infant Abdominal Infections

Antibiotic Approved for Treating Infant Abdominal Infections

29 May 2015

Read more 
Salix Announces FDA Approval of Xifaxan 550 mg for the Treatment of IBS-D

Salix Announces FDA Approval of Xifaxan 550 mg for the Treatment of IBS-D

28 May 2015

Read more 
Actavis Receives FDA Approval for Viberzi (Eluxadoline) for the Treatment of IBS-D in Adults

Actavis Receives FDA Approval for Viberzi (Eluxadoline) for the Treatment of IBS-D in Adults

28 May 2015

Read more 
GVK Biosciences: EMA Confirms Recommendation to Suspend Medicines Over Flawed Studies

GVK Biosciences: EMA Confirms Recommendation to Suspend Medicines Over Flawed Studies

27 May 2015

Read more